St Jude buys back eight million shares:
This article was originally published in Clinica
St Jude Medical has bought back 8 million shares at $38 per share in a Dutch auction self-tender offer. The shares represent 8.7% of the company's outstanding shares. The company, which is based in St Paul, Minnesota, says the buy-back of shares is an attractive use of financial resources.
You may also be interested in...
Third round of orders would give the US all the vaccine it needs from the existing mRNA products, taking pressure off AstraZeneca is it experiences manufacturing challenges and the EU considers export restrictions to ensure it gets enough vaccine.
Listerine mouthwash drove J&J’s oral care sales up 11.4% in the fourth quarter. Tylenol for adults was the star of its OTC drug business but weakness of children’s Tylenol products and other OTCs led to flat sales.
Nutritional Brands rolls out NB Pure as brand, including logo, packaging design and website, for all its supplements after 25 years. “When you looked at our label for one brand and looked at the label for another brand, there was no symmetry between the two,” says CEO Danna Pratt.